Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06651606 · ClinicalTrials.gov registry record · NA
Preventing Relapse of Problem Behavior Through Behavioral Economics: A Translational Analysis
A NA study of Problem Behavior, sponsored by Oakland University.
- Recruiting
- Registry status
- NA
- Development phase
- 24
- Enrollment target
- 2
- Study locations
NCT06651606: Recruiting NA study of Problem Behavior, sponsored by Oakland University.
NCT06651606 is a NA study of Problem Behavior that is actively recruiting participants, run by Oakland University. The registered enrollment target is 24 participants, below the 3,105-participant average among 11 other Problem Behavior trials with a reported enrollment target (99% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06651606, a NA study of Problem Behavior, is actively recruiting participants, sponsored by Oakland University.
- RECRUITING
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
- 2
- Study locations
Study Summary
The goal of this clinical trial is to compare a novel tactic for mitigating reinstatement compared to the current standard of care approach using a translational-treatment model. The main questions it aims to answer are: 1. how well does progressive ratio training mitigate response-dependent reinstatement compared to the standard of care approach? 2. how well does progressive ratio training mitigate response-independent reinstatement compared to the standard of care approach?
Primary Outcome
The number of individuals for whom treatment remains effective (either progressive ratio training or current standard-of-care), which investigators will determine by comparing the mean rate of responding in baseline and subsequent conditions (Treatment and Reinstatement Tests 1 and 2). If investigators find at least an 80% reduction in target behavior in a condition (a standard clinical target for problem behavior), they will conclude that the treatment is effective (or remains effective).
Conditions Studied
Interventions
- BEHAVIORAL Progressive Ratio Training (PRT)
- BEHAVIORAL Differential Reinforcement of Alternative (DRA) Behavior with Extinction
Study Locations (2)
Alabama
- Auburn University - Auburn
Michigan
- Oakland University - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2024-09-30 |
| Est. Completion | 2026-09-10 |
| Phase | NA |
What NCT06651606 shows while recruiting
NCT06651606 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 3,105-participant average among 11 other Problem Behavior trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Problem Behavior appearing as the primary indexed condition, and to 2 interventions - of which Progressive Ratio Training (PRT) is the first listed.
NCT06651606 reports a single indexed study location in Alabama, Michigan.
Frequently Asked Questions
What is clinical trial NCT06651606 about?
NCT06651606 is a clinical study titled "Preventing Relapse of Problem Behavior Through Behavioral Economics: A Translational Analysis". The goal of this clinical trial is to compare a novel tactic for mitigating reinstatement compared to the current standard of care approach using a translational-treatment model. The main questions it aims to answer are: 1. how well does progressive ratio training mitigate response-dependent reinst...
What is the current status of trial NCT06651606?
This trial is currently recruiting. It is a NA study. The enrollment target is 24 participants. The study started on 2024-09-30. Estimated completion is 2026-09-10.
What conditions does trial NCT06651606 study?
This clinical trial studies the following conditions: Problem Behavior.
What interventions are being tested in trial NCT06651606?
The interventions under investigation include: Progressive Ratio Training (PRT) (BEHAVIORAL), Differential Reinforcement of Alternative (DRA) Behavior with Extinction (BEHAVIORAL).
Who is sponsoring clinical trial NCT06651606?
This trial is sponsored by Oakland University, which has 9 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06651606 being conducted?
This trial has 2 study locations across Alabama, Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Problem Behavior
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06651606's enrollment target sits among peer trials
24 9th of 11 higher than 3 of 11 other Problem Behavior trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Problem Behavior trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Manualized Assessment and Treatment Model of Challenging Behavior
RECRUITING · NA
-
Digital Therapeutics for Behavior Problems
RECRUITING · NA
-
Basic and Applied Research on Extinction Bursts
RECRUITING · NA
-
Problem Behavior Assessment and Intervention in IDEA Part C Services
RECRUITING · NA
-
Extensions of Resurgence as Choice
RECRUITING · NA
-
Parent Training for Parents of Toddlers Born Very Premature:
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02331979 · 24 participants · NA
Improving Bladder Function in SCI by Neuromodulation
- NCT03096197 · 24 participants · NA
Exoskeleton and Spinal Cord Stimulation for SCI
- NCT03223922 · 24 participants · NA
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
- NCT03326921 · 24 participants · Phase 1
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI